Bättwil, Switzerland

Daniel Obrecht

USPTO Granted Patents = 67 

 

 

Average Co-Inventor Count = 5.5

ph-index = 10

Forward Citations = 324(Granted Patents)


Inventors with similar research interests:


Location History:

  • Basel, CH (2005 - 2007)
  • Blättwil, CH (2011 - 2014)
  • Blättwil, CN (2014)
  • Battwil, CH (2009 - 2020)
  • Baettwil, CH (2013 - 2022)
  • Bättwil, CH (2008 - 2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Beta-Hairpin Peptidomimetics
Template-Fixed Peptidomimetics
Backbone-Cyclized Peptidomimetics
Macrocyclic Compounds
Piperidine Derivatives
Piperazine Derivatives
Antimicrobial Activity
Protease Inhibitors
CXCR4 Antagonists
CXCR7 Modulating Activity
Elastase Inhibitors
FPR1 Inhibitors
67 patents (USPTO):Explore Patents

Innovator Spotlight: Daniel Obrecht

Introduction

Daniel Obrecht, located in Bättwil, Switzerland, is a prolific inventor with an impressive portfolio of 67 patents to his name. His contributions to the field of antimicrobial compounds highlight his innovative spirit and commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents are two significant contributions related to Beta-hairpin peptidomimetics. The first patent involves Beta-hairpin peptidomimetics of the general formula (I), specifically cyclo[P-P-P-P-P-P-P-P-P-P-P-P-T-T]. These compounds and their pharmaceutically acceptable salts demonstrate Gram-negative antimicrobial activity and can effectively inhibit the growth or kill various microorganisms. They serve as potential medicaments for treating or preventing infections, as well as disinfectants for foodstuffs, cosmetics, and nutrient-containing materials. These peptidomimetics are manufactured through a mixed solid- and solution-phase synthetic strategy.

The second patent also focuses on Beta-hairpin peptidomimetics of the general formula (I), encompassing components such as P, X, Q, and optionally L, as defined in the associated description and claims. Similar to the first, these compounds show significant Gram-negative antimicrobial activity and potential applications in medical and disinfectant products.

Career Highlights

Daniel Obrecht has made substantial contributions during his tenure in the pharma industry. Notably, he has worked with Polyphor AG and Polyphor Ltd., where his expertise in peptide chemistry has led to innovative developments in the field of antimicrobial agents.

Collaborations

Throughout his career, Daniel has collaborated with esteemed professionals such as Frank Gombert and Christian Ludin. These partnerships have undoubtedly fostered an environment of creativity and innovation, which is essential for advancing scientific research and product development in healthcare.

Conclusion

Daniel Obrecht's extensive patent portfolio and collaborations underscore his significant impact on the scientific community. His work on Beta-hairpin peptidomimetics, in particular, showcases his commitment to addressing critical healthcare challenges through innovative solutions. As he continues to make strides in his field, the influence of his inventions on medicine and public health is sure to be profound.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…